Amsterdam 2013 Programme Satellite Meetings Registration Exhibition Virtual Exhibition Hotels Visa Letter Invitation
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Primary phacoemulsification and intraocular lens implantation for primary angle closure glaucoma

Poster Details

First Author: H.El Sobky EGYPT

Co Author(s):    A. Sarhan              

Abstract Details



Purpose:

to evaluate effects and safety of primary phacoemulsification and intraocular lens implantation in patients with controlled chronic angle closure glaucoma (CACG) or primary angle closure (PAC) with or without cataract.

Setting:

Ophthalmology Development, Menoufia University Hospital, Shibin El kom, Egypt.

Methods:

phacoemulsification plus intraocular lens implantation were done in 32 eyes of 32 patients, 8 patient had coexisting mild cataract and 24 patients presented with clear lens. Intra ocular pressure (IOP), visual acuity, anterior champer depth (ACD), number of antiglaucoma medication were evaluated.

Results:

The post operative IOP was reduced in all eyes (100%). Preoperative IOP was 46.76+ 14.62 mm Hg, which decreased postoperatively to 17.55+9.54 mm Hg at 1 day, 11.65+2.65 mm Hg at 1 month and 10.60+2.23 mm Hg at 3months (p<0.001). The number of antiglaucoma medication decreased from 3.76+1.11 to 0.13+0.32 (p<0.001). Preoperative ACD was 2.04+ 0.31 which increased to 3.54 +0.32 mm postoperatively (p<0.001). Visual acuity improved from 1.12+ 0.67 to 0.74+0.53 (p<0.001). unE may, vao day coi co con nho nay ngon lam http://nhatquanglan.xlphp.net/ E may, vao day coi co con nho nay ngon lam http://nhatquanglan.xlphp.net/ FC:WINDOWShinhem.scro

Conclusions:

primary phacoemulsification plus intraocular lens implantation seems to be a safe and effective method in lowering IOP, reducing the use of antiglaucoma medications and improving vision and can be considered a first treatment of choice in patients with controlled CACG or PAC.

Financial Disclosure:

NONE

Back to previous